Article Contents ::
- 1 Details About Generic Salt :: Glatiram
- 2 Main Medicine Class:: Immune modifier
- 3 (glah-TEER-ah-mer ASS-eh-tate) Copaxone Class: Immune modifier
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Glatiram
Main Medicine Class:: Immune modifier
(glah-TEER-ah-mer ASS-eh-tate)
Copaxone
Class: Immune modifier
Drugs Class ::
Action Unknown. May modify the immune processes that are thought to be responsible for multiple sclerosis (MS).
Indications for Drugs ::
Indications To reduce the frequency of relapses in patients with relapsing-remitting MS.
Drug Dose ::
Route/Dosage
ADULTS: SC 20 mg q day.
Contraindication ::
Contraindications Hypersensitivity to glatiramer acetate or mannitol.
Drug Precautions ::
Precautions
Pregnancy: Category B. Lactation: Undetermined. Children: Safety and efficacy in children < 18 not established. Immunity: Could possibly interfere with useful immune function (eg, decreased defense against infection or tumor surveillance). Immediate post-injection reaction: Approximately 10% of patients experience a constellation of symptoms immediately after injection. Symptoms may include: Flushing; chest pain; palpitations; anxiety; dyspnea; constriction of throat; urticaria. These symptoms are usually transient and self-limited and generally occur several months after starting therapy.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CV: Vasodilation; chest pain; palpitations; tachycardia; syncope; hypertension. CNS: Anxiety; depression; migraine headache; asthenia; hypertonia; tremor; dizziness; nervousness; agitation; confusion; abnormal dreams; emotional liability; stupor; foot drop. DERM: Rash; pruritis; sweating; flushing; urticaria; nodules. GI: Nausea; diarrhea; vomiting; anorexia; oral moniliasis. GU: Urinary urgency; vaginal moniliasis; dysmenorrhea. HEMA: Ecchymosis; lymphadenopathy. META: Peripheral edema; edema of face; weight gain. EENT: Nystagmus; ear pain; rhinitis; laryngismus. RESP: Dyspnea; bronchitis; hyperventilation. OTHER: Pain; fever; chills; “flu-like” syndrome; arthralgia; injections site reaction (pain, erythema, inflammation, pruritis, induration, welt, hemorrhage, urticaria, atrophy, abscess, mass); infection; neck pain.
Drug Mode of Action ::
Action Unknown. May modify the immune processes that are thought to be responsible for multiple sclerosis (MS).
Drug Interactions ::
Interactions None well documented.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history.
- Assess patient for GI, CNS, CV, RESP, and DERM reactions. If present, notify health care provider.
- Monitor results of laboratory tests.
Drug Storage/Management ::
Administration/Storage
- For SC use only. Do not administer IV.
- Reconstitute with supplied diluent (Sterile Water for Injection). Gently swirl vial and let stand at room temperature. Do not shake.
- Do not use if solution contains particulate matter.
- Use immediately after reconstitution because there is no preservative. Discard any unused solution.
- Administer SC with 27–gauge needle into arm, abdomen, hip, or thigh.
- Rotate injection sites, not repeating same site more than once weekly.
- Store unreconstituted glatiramer acetate in freezer. Diluent may be stored at room temperature.
Drug Notes ::
Patient/Family Education
- Ensure that patient or responsible family member has been instructed in the proper storage, preparation, and injection technique.
- Provide patient information booklet and discuss.
- Advise patient to not change the dose, dosing schedule, or discontinue the medication without consulting with his/her health care provider.
- Advise female patient to notify her health care provider if she becomes pregnant or intends to become pregnant or is breastfeeding while taking this drug.
- Provide puncture-resistant container for disposal of used syringes and needles. Instruct patient in proper disposal of container when full.
- Instruct patient to report symptoms that may represent side effects: Chest pain; pounding in chest; “flu-like” symptoms; pain or other injection-site reactions; headache; fever; breathing difficulty; anxiety; tremors; nervousness; rash; itching; hives; blotchy swelling.